Multicenter, retrospective registry to collect 9-12 month follow-up data to evaluate major adverse cardiac events in patients whom have undergone percutaneous coronary intervention and received either Taxus Liberte or Xience V.

Inclusion Criteria:

• Patients 18 years of age or older, both genders
• Underwent PCI with Taxus Liberte (alone) or Xience (alone)

Exclusion Criteria:

• Underwent PCI with a non-Taxus Liberte or Xience V DES during the same procedure
• Received both Taxus-Liberte and Xience-V during the same index procedure
• Patients not taking, or unable to take, dual antiplatelet therapy (aspirin plus clopidogrel or prasugrel).

Patients male or female, 18 years or older whom have undergone PCI with either Taxus Liberte or Xience V